高血压治疗药物依普利酮哪里有？

Where can I find medicines to treat high blood pressure?

Eplerenone (Inspra) is an oral drug approved for marketing in the United States in 2002. It is a new highly selective aldosterone receptor blocker that can be used for the treatment of heart failure, hypertension, and coronary heart disease. Eplerenone (Inspra) blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone system (RAAS), by binding to the mineralocorticoid receptor. Currently, the most cost-effective product on the market is the Indian version of eplerenone (Inspra), with a specification of 50mg*100 tablets and a price of around $420. Since the exchange rate floating price is not fixed, if patients want to know the specific price information of the drug, or want to purchase the drug overseas, they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).

In recent years, more and more evidence has shown that other tissues, especially the brain, heart and blood vessels, can also independently synthesize aldosterone. Not only that, it can also directly affect blood pressure, damage the heart, brain, kidneys and other organs, seriously affecting the patient's health. Eplerenone is a selective aldosterone receptor antagonist that only acts on mineralocorticoid receptors and does not act on androgen and progesterone receptors. It has fewer side effects.

Treatment with eplerenone (Planep) should be used with caution in patients with diabetes and post-myocardial infarction heart failure (especially those with proteinuria), as this may increase the risk of hyperkalemia.

Treatment with eplerenone may cause kidney damage. As kidney function decreases, the risk of hyperkalemia increases. Use with caution in patients with mild renal impairment; eplerenone may be disabled depending on the indications and degree of impairment.

Patients should also be aware of drug-drug interactions. Significant interactions may exist with eplerenone, requiring dose or frequency adjustment, additional monitoring, and/or the selection of alternative therapies.

The above is the introduction about (eplerenone), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/83266.html